Related Experiment Video
Updated: Mar 26, 2026

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
Published on: February 28, 2025
Challenges and Opportunities in Drug Delivery for Wound Healing
Alexander J Whittam1, Zeshaan N Maan1, Dominik Duscher1
1Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University School of Medicine , Stanford, California.
Abstract:
Significance: Chronic wounds remain a significant public health problem. Alterations in normal physiological processes caused by aging or diabetes lead to impaired tissue repair and the development of chronic and nonhealing wounds. Understanding the unique features of the wound environment will be required to develop new therapeutics that impact these disabling conditions. New drug-delivery systems (DDSs) may enhance current and future therapies for this challenging clinical problem. Recent Advances: Historically, physical barriers and biological degradation limited the efficacy of DDSs in wound healing. In aiming at improving and optimizing drug delivery, recent data suggest that combinations of delivery mechanisms, such as hydrogels, small molecules, RNA interference (RNAi), as well as growth factor and stem cell-based therapies (biologics), could offer exciting new opportunities for improving tissue repair. Critical Issues: The lack of effective therapeutic approaches to combat the significant disability associated with chronic wounds has become an area of increasing clinical concern. However, the unique challenges of the wound environment have limited the development of effective therapeutic options for clinical use. Future Directions: New platforms presented in this review may provide clinicians and scientists with an improved understanding of the alternatives for drug delivery in wound care, which may facilitate the development of new therapeutic approaches for patients.
Insights
Chronic wounds, often caused by aging or diabetes, impair tissue repair. Novel drug-delivery systems (DDSs) combining therapies show promise for improving healing outcomes in nonhealing wounds.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Wound Healing Research
Background:
- Chronic wounds represent a significant public health challenge, particularly in aging populations and individuals with diabetes.
- Impaired tissue repair mechanisms in these groups contribute to the development of nonhealing wounds, leading to considerable disability.
- Current therapeutic strategies face limitations due to the complex wound environment.
Conclusions:
- Addressing the challenges of chronic wounds requires innovative therapeutic approaches.
- Advanced DDSs, particularly those employing combination strategies, are crucial for enhancing tissue repair.
- Further research into new drug-delivery platforms will facilitate the development of next-generation therapies for nonhealing wounds.
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Oral Drug Delivery Systems: Introduction
Modified-Release Drug Delivery Systems: Stimuli-Activated
Transdermal Drug Delivery Systems

